Latest News for: efficacy
Edit
ICYMI: Bennet Questioning Leads Kennedy to Acknowledge Safety and Efficacy of Measles Vaccine (Michael F Bennet)
Public Technologies 24 Apr 2026
). Apr 23, 2026 . Press Releases. Video of Bennet's Full Line of Questioning During the Hearing is Available HERE. Washington, D.C. - Colorado U.S. Senator Michael Bennet pressed U.S. Health and Human Services (HHS) Secretary Robert F. Kennedy Jr ... Collins.
Edit
New Study Highlights Safety and Efficacy Profile of Haemonetics' VASCADE MVP® XL in Large-Bore Venous Access Closure Procedures
PR Newswire 24 Apr 2026
BOSTON, April 24, 2026 /PRNewswire/ -- Haemonetics Corporation (NYSE ... A Single-Center Experience on Efficacy and Complications," was published earlier this week in the Journal of Cardiovascular Electrophysiology ... In March 2026, the U.S ... CT ... CT ... 21% ... .
Edit
Rapid City Journal
23 Apr 2026
Feds will not publish vaccine efficacy report
A report showing the efficacy of COVID-19 vaccines ...
Edit
Nectero Therapeutics Reports Two-Year Safety and Efficacy Data from First-in-Human Trial for Treatment of Small- ...
Nasdaq Globe Newswire 23 Apr 2026
The results were presented at Charing Cross 2026 by Dr ... .
Edit
US blocks COVID-19 vaccine efficacy report from CDC journal
Daily Sabah 22 Apr 2026
A report on the effectiveness of COVID-19 vaccines has been blocked from publication in the U.S. Centers for Disease Control and Prevention’s flagship scientific journal, a spokesp ....
Edit
Miv-cel (Mivocabtagene Autoleucel; KYV-101), CD19 CAR T-Cell Therapy Shows Efficacy and Safety in Stiff Person Syndrome in a Pivotal, Multicenter, Phase 2 Study (KYSA-8) (Kyverna Therapeutics Inc)
Public Technologies 22 Apr 2026
). The text version of this document is not available ... Attachments Permalink. Disclaimer.
Edit
BeyondSpring Reports Compelling New Data: Plinabulin Advances Both the Anticancer Efficacy and Safety of ADC Drugs
Nasdaq Globe Newswire 22 Apr 2026
Edit
Citizen Tribune
22 Apr 2026
Actinium Pharmaceuticals, Inc. Announces Compelling Pan-Tumor Data for ATNM-400 Demonstrating Broad Efficacy Across Prostate, Lung, ...
ATNM-400 demonstrates pan-tumor activity across prostate, lung, and ...
Edit
Journal of Prevention of Alzheimer’s Disease publishes results from confirmatory TauRx study into efficacy of potential oral treatment
Pharmiweb 22 Apr 2026
The new paper, titled Assessment of clinical and neuroimaging efficacy of treatment targeting tau pathology in mild cognitive impairment and mild to moderate Alzheimer’s disease with ...
Edit
CDC won’t publish report showing efficacy of the COVID-19 vaccine
Detroit news 22 Apr 2026
A report showing the efficacy of the COVID-19 vaccine that was previously delayed by the head of the Centers for Disease Control and Prevention has been blocked from being published in the agency’s ...
Edit
Actinium Pharmaceuticals, Inc. Announces Compelling Pan-Tumor Data for ATNM-400 Demonstrating Broad Efficacy Across Prostate, Lung, and Breast Cancer Models at the 2026 American Association of Cancer Research Annual Meeting
PR Newswire 22 Apr 2026
Edit
RedHill's Opaganib Enhances Efficacy of Neuroblastoma Chemo Combination and Augment Anti-Tumor Immunity in Triple-Negative Breast Cancer in Preclinical Studies - New Data Presented at AACR 2026
PR Newswire 22 Apr 2026
Opaganib, a novel, potentially broad acting, oral, small molecule drug with demonstrated safety & efficacy profiles[4], is in development for multiple oncology, viral, inflammatory and diabetes and obesity-related indications.
Edit
Preclinical Development of ATNM-400, a First-in-Class Actinium-225 Radioconjugate with Pan-Tumor Efficacy in Solid Tumors (Actinium Pharmaceuticals Inc)
Public Technologies 22 Apr 2026
Preclinical Development of ATNM-400, a First-in-Class Actinium-225 Radioconjugate with Pan-Tumor Efficacy in Solid Tumors ... Clonogenic Efficacy ... ATNM-400 efficacy versus HER2-ADC (DXd) was comparable.
Edit
Medicenna Presents Positive Data Demonstrating Superior Safety and Efficacy Potential of its First-in-Class anti-PD-1 x ...
Nasdaq Globe Newswire 21 Apr 2026
New in vivo data demonstrate exceptional selectivity, localization and potency of MDNA113 in the tumor and tumor microenvironment while enhancing the systemic tolerability profile ... .
- 1
- 2
- Next page »